650 related articles for article (PubMed ID: 7948129)
21. A murine leukemia virus (MuLV) long terminal repeat derived from rhesus macaques in the context of a lentivirus vector and MuLV gag sequence results in high-level gene expression in human T lymphocytes.
Kung SK; An DS; Chen IS
J Virol; 2000 Apr; 74(8):3668-81. PubMed ID: 10729143
[TBL] [Abstract][Full Text] [Related]
22. Expression of phosphoenolpyruvate carboxykinase (PEPCK) chimeras in renal epithelial cells. Retention of appropriate physiological responsiveness using enhancerless retroviral vectors.
Pollock AS; Lovett DH
Biochem J; 1992 Jun; 284 ( Pt 3)(Pt 3):725-32. PubMed ID: 1377912
[TBL] [Abstract][Full Text] [Related]
23. Multiple modifications allow high-titer production of retroviral vectors carrying heterologous regulatory elements.
Hlavaty J; Stracke A; Klein D; Salmons B; Günzburg WH; Renner M
J Virol; 2004 Feb; 78(3):1384-92. PubMed ID: 14722293
[TBL] [Abstract][Full Text] [Related]
24. Retroviral vector design for long-term expression in murine hematopoietic cells in vivo.
Correll PH; Colilla S; Karlsson S
Blood; 1994 Sep; 84(6):1812-22. PubMed ID: 8080986
[TBL] [Abstract][Full Text] [Related]
25. Regulation of gene expression directed by the long terminal repeats of feline leukemia viruses.
Nishigaki K; Endo Y; Matsumoto Y; Watari T; Goitsuka R; Tsujimoto H; Hasegata A
Leukemia; 1997 Apr; 11 Suppl 3():189-92. PubMed ID: 9209339
[TBL] [Abstract][Full Text] [Related]
26. Construction of human factor IX expression vectors in retroviral vector frames optimized for muscle cells.
Wang JM; Zheng H; Sugahara Y; Tan J; Yao SN; Olson E; Kurachi K
Hum Gene Ther; 1996 Sep; 7(14):1743-56. PubMed ID: 8886845
[TBL] [Abstract][Full Text] [Related]
27. A retroviral vector suitable for ultrasound image-guided gene delivery to mouse brain.
Jang J; Yoon K; Hwang DW; Lee DS; Kim S
Gene Ther; 2012 Apr; 19(4):396-403. PubMed ID: 21900964
[TBL] [Abstract][Full Text] [Related]
28. High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS.
Plavec I; Agarwal M; Ho KE; Pineda M; Auten J; Baker J; Matsuzaki H; Escaich S; Bonyhadi M; Böhnlein E
Gene Ther; 1997 Feb; 4(2):128-39. PubMed ID: 9081703
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of lymphoid-specific enhancer addition or substitution in a basic retrovirus vector.
Moore KA; Scarpa M; Kooyer S; Utter A; Caskey CT; Belmont JW
Hum Gene Ther; 1991; 2(4):307-15. PubMed ID: 1838933
[TBL] [Abstract][Full Text] [Related]
30. The effect of selection for high-level vector expression on the genetic and functional stability of a single transcript vector derived from a low-leukemogenic murine retrovirus.
Duch M; Paludan K; Lovmand J; Sørensen MS; Jørgensen P; Pedersen FS
Hum Gene Ther; 1995 Mar; 6(3):289-96. PubMed ID: 7779912
[TBL] [Abstract][Full Text] [Related]
31. A novel expression vector composed of a regulatory element of the human leukosialin-encoding gene in different types of mammalian cells.
Xu A; Kudo S; Fukuda M
Gene; 1995 Jul; 160(2):283-6. PubMed ID: 7642111
[TBL] [Abstract][Full Text] [Related]
32. Activity of Friend mink cell focus-forming retrovirus during myelo-erythroid hematopoiesis.
Baum C; Eckert HG; Stocking C; Ostertag W
Exp Hematol; 1996 Feb; 24(2):364-70. PubMed ID: 8641367
[TBL] [Abstract][Full Text] [Related]
33. Retroviral vector sequences may interact with some internal promoters and influence expression.
Wu X; Holschen J; Kennedy SC; Ponder KP
Hum Gene Ther; 1996 Jan; 7(2):159-71. PubMed ID: 8788167
[TBL] [Abstract][Full Text] [Related]
34. Harvey murine sarcoma virus/MDR1 retroviral vectors: efficient virus production and foreign gene transduction using MDR1 as a selectable marker.
Metz MZ; Best DM; Kane SE
Virology; 1995 Apr; 208(2):634-43. PubMed ID: 7747435
[TBL] [Abstract][Full Text] [Related]
35. Selection of transduced CD34+ progenitors and enzymatic correction of cells from Gaucher patients, with bicistronic vectors.
Migita M; Medin JA; Pawliuk R; Jacobson S; Nagle JW; Anderson S; Amiri M; Humphries RK; Karlsson S
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12075-9. PubMed ID: 8618847
[TBL] [Abstract][Full Text] [Related]
36. Various modes of basic helix-loop-helix protein-mediated regulation of murine leukemia virus transcription in lymphoid cell lines.
Nielsen AL; Nørby PL; Pedersen FS; Jørgensen P
J Virol; 1996 Sep; 70(9):5893-901. PubMed ID: 8709209
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the expression of a mutant dihydrofolate reductase under control of different internal promoters in retroviral vectors.
Li M; Hantzopoulos PA; Banerjee D; Zhao SC; Schweitzer BI; Gilboa E; Bertino JR
Hum Gene Ther; 1992 Aug; 3(4):381-90. PubMed ID: 1525211
[TBL] [Abstract][Full Text] [Related]
38. Correction of the enzyme deficiency in hematopoietic cells of Gaucher patients using a clinically acceptable retroviral supernatant transduction protocol.
Xu L; Stahl SK; Dave HP; Schiffmann R; Correll PH; Kessler S; Karlsson S
Exp Hematol; 1994 Feb; 22(2):223-30. PubMed ID: 8299741
[TBL] [Abstract][Full Text] [Related]
39. Hormonal control of interacting promoters introduced into cells by retroviruses.
Hatzoglou M; Bosch F; Park EA; Hanson RW
J Biol Chem; 1991 May; 266(13):8416-25. PubMed ID: 2022656
[TBL] [Abstract][Full Text] [Related]
40. Genetic instability of a MoMLV-based antisense double-copy retroviral vector designed for HIV-1 gene therapy.
Junker U; Böhnlein E; Veres G
Gene Ther; 1995 Nov; 2(9):639-46. PubMed ID: 8548553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
